Molecular biologist Andrew Holland receives President s Frontier Award
The $250,000 Johns Hopkins award recognizes scholars who are on the cusp of becoming leaders in their fields By Saralyn Cruickshank / Published Feb 15, 2021
Cell division is the fundamental process for life. But when it goes awry, life itself can be threatened.
The fragile balance of centrosomes within animal cells and the cellular functions these organelles control are essential to a form of cell division called mitosis. That s where molecular biologist Andrew Holland focuses his research. We ve been trying to understand if there are differences in the way healthy cells and tumor cells divide, and if we can exploit those differences in therapies to selectively destroy dividing tumor cells and spare the healthy cells, said Holland, an associate professor in the Department of Molecular Biology and Genetics and the Department of Oncology at the Johns Hopkins Schoo
Share this article
Share this article
TAMPA, Fla., Feb. 1, 2021 /PRNewswire/ Today, the American Association of Kidney Patients (AAKP), the nation s largest independent kidney patient organization and a global champion for patient care choice and treatment innovation, released the results of a patient membership survey,
Kidney Patients and the COVID-19 Vaccine. AAKP Flash Surveys are conducted under AAKP s Center for Patient Research and Education, which provides key kidney community insights to elected and appointed federal and state policymakers through patient survey and polling data. The Center also coordinates kidney patient engagement in medical research, clinical trials, and patient inclusion on key federal agency policy panels.
168 Health Research Report WHITE PAPER /ROUGH COPY 168th Issue Date 16 NOV 2013 Compiled By Ralph Turchiano http://www.vit.bz www.youtube.com/vhfilmhttp://www.engineeringevil.comhttp://www.healthresearchreport.me In this Issue: 1. The most commonly prescribed treatment for Colds and Sore Throats offers no benefit and… Read More ›
Last winter, JaMarcus Crews forced his feet, however numb, to walk a paved public track in the town of Centreville, Alabama, until his calves cramped and sweat bloomed across his T-shirt. He knew the route well, from Library Street to Hospital Drive. He’d walked it as a kid, when he was diagnosed with Type 2 diabetes and determined to shed weight. With freckled cheeks and soft eyes, JaMarcus was built big: 6-foot-1, wide shoulders, a round torso on skinny legs. Now, at the age of 36, he was back again. The diabetes had destroyed his kidneys, and he was trying to slim down so that he could get a transplant.